Symposium speakers describe numerous ways to promote prevention, resilience, healing and wellness after early life stresses

With full genetic control and visibility into neural activity and behavior, MIT scientists map out chemical’s role in behavior

Neurons that form part of a memory circuit are among the first brain cells to show signs of neurodegeneration in Alzheimer’s disease.

The peptide blocks a hyperactive brain enzyme that contributes to the neurodegeneration seen in Alzheimer’s and other diseases.

Blood flow induced by visual stimulation drives the flow of cerebrospinal fluid

A new study tests an alternative to external stimulation for measuring when subjects lose and regain responsiveness during sedation and anesthesia.

Teens from area high schools got the chance to learn about advanced biology and brain research on field trips to MIT

Brain applies rhythms to physical patches of the cortex to selectively control just the right neurons at the right times to do the right things.

When astrocyte function is disrupted, neurons in the brain’s motor cortex struggle to execute and refine motion, a new study in mice shows.

On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1, as the first drug available to treat Rett syndrome. The original research showing that IGF-1 could treat Rett syndrome was published by MIT in 2009.

Neuroscientists are finding that immune system activity within the brain and the body has important impacts on mental health and behavior

Young neuroscientists contributed their perspectives as the MIT Museum works to create a potential ‘Center for Neuroscience & Society’